The scarcity of published papers on muscle tension dysphonia has required that this literature review span a period of many years to yield useful information. Two primary sections are included, focusing on differential diagnosis of and therapy for this disorder. The authors complete the discussion with reference to the recently reported treatment approach that they have developed.
Introduction
Muscle tension dysphonia (MTD) is an unusual disorder because the characteristic features are perceptually striking and similar to those of spasmodic dysphonia. Patients typically exhibit hoarse-harsh-shrill vocal quality, variable pitch breaks and intermittent falsetto features, reduced maximum phonation time, episodic voice arrests, and vocal fatigue; complaints of neck, tongue, and jaw musculature hypertension are not uncommon. The overall severity of such signs and symptoms can range from mild to profound. The diagnosis is ordinarily based upon results of clinical voice appraisal and laryngoscopic examination. Whereas the etiology is usually elusive, otolaryngologists and speech-language pathologists generally agree that this condition is not typically caused by vocal fold structural lesions or neuropathology. Rather, it is considered to be a manifestation of excessive laryngeal musculoskeletal tension and associated hyperfunctional true and/or false vocal fold vibratory patterns. Possible causal relationships have been ascribed to a complex blend of emotional, psychological, and social histories that are common denominators in many patients with MTD. Occasionally, the condition results as a consequence of faulty physiologic compensation for an underlying true vocal fold pathology.
The purposes of this paper are twofold: (1) to review the information base on this voice disorder, relative to the most salient differential diagnostic and therapeutic data published during the past 7 years, and (2) to describe our own recent successes in the treatment of patients with MTD.
Diagnosis of muscle tension dysphonia Classification
In 1993, Morrison and Rammage [1] suggested that the term "functional" dysphonia is intrinsically ambiguous. They proposed an alternative classification based upon commonly occurring descriptive features of vocal fold dysfunctioning in patients who present initially with structurally normal larynges: "Muscle misuse voice disorder" was suggested as a more accurate diagnostic label. Within this framework, the term "muscular tension dysphonia" was used generically to classify six different subtypes of muscle misuse, vocal fold vibratory patterns, and resulting pathologies. Of these, the Type 2 "glottic" and "supraglottic" forms most closely resemble the profile earlier described for patients with MTD. In the former case, hyperadduction of the vocal folds 169
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James Paul Dworkin, PhD, * Robert J. Meleca, MD, * and G.G. Abkarian, PhD † produces high laryngeal resistance forces, effortful and harsh-shrill vocal quality, odynophonia, and vocal fatigue signs and symptoms. These researchers highlighted that videostroboscopy in patients with this muscle misuse voice disorder subtype usually demonstrates (1) generalized erythema and diffuse thickening of the laryngeal mucosa, (2) prolongation of the closed phases of vibration, (3) reduced amplitude of vibration, (4) suppression of the mucosal wave feature, and (5) intermittent hyperactivity of the ventricular folds. Patients with the supraglottic subtype were described as exhibiting either tightly adducted true vocal folds leading to high-pitched voice characteristics, or loose partially abducted vocal folds and associated breathy or tense-whispered vocal quality. These researchers suggested that in those patients who suffer from strident or squeaky voices, the true and false vocal folds appear to function as a valvular unit to generate voice. The underlying etiology was argued to be unresolved psychological conflict; as a consequence, therapy to combat this problem must combine behavioral therapy techniques to correct the muscle misuse patterns and careful evaluation and management of the possible psychological contributors.
Pathophysiology
In 1994, Titze [2] examined variable vocal fold mechanical loads and deformations that occur during normal and maximal effort voice activities. He was most interested in determining the extent to which tensile, contractile, collision, inertial, aerodynamic, arytenoid contact, and shearing phonatory stressors may damage vocal fold tissue. Of these, tensile stress was reported to be potentially the most harmful to the health of the vocal folds. Titze illustrated that levels of vocal fold tension are directly proportional to the pitch of the voice; tensile stress was shown to load the longitudinal fibers of the vocal ligaments, which normally serve as shock absorbers during phonation. It was suggested that these ligaments cannot, however, protect against excessive vocal fold collision forces associated with chronically high-pitched voice behaviors. Though Titze did not attempt to correlate his findings with specific types of voice-disordered populations, by extension it is interesting to speculate about the possible vocal fold pathophysiologic effects of MTD. As previously mentioned, patients with this condition typically exhibit ultra high-pitched voice characteristics and high levels of intrinsic and extrinsic laryngeal musculoskeletal tension. Based on his findings, it is not illogical to caution that patients who struggle with persistent MTD signs and symptoms may be at risk for eventually developing harmful vocal fold tissue reactions that may require both behavioral therapy and phonosurgery for voice remediation.
Electromyography
In 1998, Hocevar-Boltezar, Janko, and Zargi [3] used surface electromyography (EMG) in the diagnosis and treatment of MTD. These authors noted that the vocal symptoms of this disorder are combined with excessive glottic and supraglottic muscle tension phenomena. Their investigation was designed to characterize the EMG patterns of different muscle groups of the lower face and anterior neck regions thought to be hypertensive in patients with MTD. Eleven adult patients with this voice diagnosis were studied and compared with five healthy controls. All patients exhibited harsh vocal quality; three developed vocal fold nodules, deemed to be secondary manifestations of the abusive MTD behaviors. EMG recordings, during silence and vowel prolongations, were obtained from nine pairs of unipolar surface electrodes fixed to the following structures: upper and lower lips, chin, submandibular triangle, thyrohyoid membrane, sternocleidomastoid muscles, below the thyroid cartilage, and strap muscles. Results were mixed and generally inconclusive. However, there were some experimental subject EMG findings worth noting. These included (1) an eightfold increase of EMG activity before the onset of and continuous throughout phonation, (2) excessive tension in the upper lip and supralaryngeal regions, and (3) occasional activity asymmetry, wherein one side of the face and neck was three times more active than the other, as compared with normal counterpart EMG signals from the same locations. It is important to note that these differences were not observed in all of the patients with MTD. Nor was it possible to decipher whether any of the EMG data obtained represented the cause or the effect of the voice difficulties exhibited by the patients. Notwithstanding the data shortcomings, these clinical researchers proposed that EMG recordings can have a role in the management of MTD. They suggested that accurate identification of hyperactive/hypertensive muscle groups in patients with MTD would enable therapists to target the involved structures during relaxation exercises; such focus could theoretically translate into improved treatment outcomes.
Speech aerodynamic measurements
In 1999, Higgins, Chart, and Schulte [4] studied the phonatory airflow characteristics of individuals with MTD, spasmodic dysphonia, and healthy voice. MTD was defined as a behavioral voice disorder associated with hyperfunctioning of either the intrinsic laryngeal musculature, extrinsic laryngeal musculature, or both. Stressful lifestyles and difficulty expressing negative emotions were considered possible contributors to the development and persistence of MTD. The following variable glottal configuration abnormalities were commonly observed by these clinical researchers in nine patients with this disorder: (1) hyperadduction of the true and false vocal folds, (2) true vocal fold hypoadduction, (3) vocal fold bowing, and (4) cartilaginous glottal chinks. These muscle tension physiologic sequelae resulted in harsh-strained and intermittent breathyhoarse vocal quality features, pitch dyscontrol, and occasional glottal fry phonation characteristics. Results of the investigation revealed no significant differences in mean airflow rate between those individuals with MTD, adductor spasmodic dysphonia, or healthy voice abilities. There were large intersubject variations in phonatory airflow in both of the experimental subgroups. Therapeutic strategies for these voice disorders were not detailed.
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Psychological counseling
In 1998, Baker [5] described the need to "peel back the layers" in therapy to achieve long lasting, satisfactory treatment outcomes. MTD was defined as a condition that is caused and exacerbated by an intricate web of psychological factors, such as anxiety, emotional stress, depression, or interpersonal conflicts. According to this clinical researcher, patients with conversion reaction aphonia, plicae ventricularis, and falsetto voice with intermittent pitch breaks may all be broadly included in this diagnostic entity. To illustrate the process of unveiling ("peeling") the underlying causes of the dysphonia, which was judged to be indispensable to the design of an effective treatment program, two cases were presented. For each of these patients, significant symptom improvements were obtained after a combination of direct and indirect voice therapy techniques and psychological counseling. The role of mental health practitioners in the treatment of patients with psychogenic dysphonias was heavily emphasized by Baker. She argued that without this component of intervention patients may not learn to deal effectively with the inner conflicts and uncomfortable situations that may be causally related to their voice problems.
Physical therapy +/-voice exercises
In 1993, Roy and Leeper [6] examined the therapeutic effects of a manual tension reduction technique on overall voice functioning in 17 patients with presumed MTD. These researchers characterized this condition as a subtype of functional dysphonia or aphonia, caused and reinforced by excessive laryngeal musculoskeletal tension, not vocal fold or neurologic abnormalities. Their treatment approach was adopted from the earlier work of Aronson [7] , who argued that high-pitched, tense voice behaviors may lead to cramping and stiffness of the hyoid-laryngeal musculature because of chronic posturing of the larynx in an elevated position during phonation. Essentially, gentle massage and kneading of the laryngeal framework and extrinsic musculature were performed in the present investigation to induce relax-ation of the target structures and to facilitate voice motor control. Aronson reported that voice improvements noted are usually proportional to the degree of muscle tension reduction achieved in therapy. Of the 17 patients studied, 16 were female. The age range for the group was 20 to 70 years; the length of time with MTD signs and symptoms ranged from 4 days in one individual to 3 years in another. Results of the study revealed that perceptual voice improvements were significant in the majority of patients after just one therapy session. Follow-up by phone 1 week posttreatment demonstrated general maintenance of phonation gains. The authors wisely cautioned that because no objective measures of suspected muscle tension, such as laryngeal electromyography, were obtained from the patients studied, the voice improvements noted could not be unequivocally attributed to the therapy regimen alone. It was suggested that complex psychologic factors, which invariably are causally related to the onset and persistence of MTD, may have also contributed to the treatment outcomes.
In 1996, Roy and his associates [8] again reported on the application of manual laryngeal tension reduction therapy for patients with laryngeal hyperfunction syndromes, such as MTD. The technique of intervention involved focal palpation of the larynx to determine several factors, including (1) extent of laryngeal elevation at rest and during voice production (bobbing), (2) tissue tenderness and pain, (3) effects on voice of downward pressure on the thyroid cartilage, and (4) degree of sustained voice improvement after therapy. Three MTD case studies were described, two of whom exhibited spasmodic dysphonia symptomatology as well. Results were marginally successful for these two patients but excellent for the individual who did not suffer from coexistent spasmodic dysphonia; she reported relief of laryngeal tightness and odynophonia, concurrent with significant gains in voice quality and control after just a single session of therapy. There was no evidence of recurrence in this case on follow-up 1 month later. In conclusion, these authors suggested that in general all dysphonic patients ought to be evaluated for the presence of excess laryngeal musculoskeletal tension. When detected, either as a primary cause or a secondary manifestation of the dysphonia, circumlaryngeal massage therapy should be included in the treatment armamentarium.
In 1997, Roy and his associates [9] once again discussed short-and long-term therapeutic benefits of manual circumlaryngeal massage in 25 patients with nonorganic or so-called functional dysphonia. These clinical researchers suggested that emotional stressors and psychological conflicts may not only cause such voice disorders, but they may exacerbate them as well. Preand posttreatment audiotape recordings were subjected to perceptual and acoustic analyses to measure immediate and longer-term outcomes of single therapy sessions. Results revealed that patients evidenced significant gains in voice functioning, both perceptually and acoustically, after circumlaryngeal massage therapy. Roughly 75% of these individuals, however, were noted to experience partial dysphonia recurrences after discharge from therapy. Overall, the authors concluded that the laryngeal massage technique they used was efficacious in the management of patients with voice difficulties that were largely caused by hyperfunctional vocal fold vibratory patterns. Because short-term effects were robust and long-term outcomes were less reliable, this therapy approach was not judged to be a definitive remedy for these types of patients.
In 1998, Jones, Murry and Rosen [10] used a case report format to demonstrate the efficacy of physical therapy as part of the multidisciplinary treatment approach to MTD. This condition was defined as one that usually involves muscles of the intrinsic larynx, neck, tongue, and jaw. These researchers warned that early detection and treatment are tantamount to rapid and complete recovery and thwart the development of damaging compensatory voice behaviors that may lead to secondary organic sequelae. A 28-year-old female was presented who complained of recurring upper respiratory infections, laryngitis, and episodic voice loss and hoarseness for many years. With the exception of mild vocal fold edema, the larynx appeared healthy on endoscopy. During phonation, anterior-posterior compression and medial movement of the ventricular vocal folds were observed. Neck palpation revealed marked tension in the cervical spine region, involving the strap, upper trapezius, and sternocleidomastoid muscles.
The physical therapy treatment program consisted of six sessions during 2 weeks, in which ultrasound, massage, stretching, general relaxation, and postural adjustment exercises were incorporated. Voice therapy consisted of two sessions during the same 2-week period, with focus on easy onset voice techniques, speech breathing practice, and prephonatory relaxed posturing; a coordinated homework program was included. Results demonstrated moderate improvements in both voice and associated head, neck, and shoulder muscle tension symptoms within 1 week. By the completion of the entire program, the patient demonstrated near-normal levels of laryngeal, cervical, and shoulder muscular activities. She reported that most of her symptoms of spasms, pain, and general physical limitations had virtually resolved as well. On follow-up by phone 7 weeks later, the patient had no complaints at all. These authors proposed that for other patients with similar complex MTD profiles, a combination of physical and voice therapy strategies may be necessary to optimize functional recovery.
In 1998, Ramig and Verdolini [11] conducted a review of the literature on the efficacy of therapy for various types of voice disorders, including those thought to be caused by psychologic stress. Patients with vocal hyperfunction or MTD signs and symptoms were mixed within this population subset. General consensus among different clinical researchers was that voice therapy should be the first-line approach to management, with the objective of improving symptoms without the need for coincident or subsequent medical, pharmacological, or surgical intervention. For some patients, collateral psychological counseling was found to be essential to successful treatment outcomes. The following types of behavioral exercises were identified as therapeutically efficacious for the improvement of musculoskeletal tension dysphonias: (1) head, neck, jaw, and shoulder progressive relaxation techniques, (2) manual circumlaryngeal massage, (3) yawnsigh vocalizations and Froeschel's Chewing technique to induce easy onset phonation and oropharyngeal musculature relaxation, (4) digital laryngeal and strap musculature pressure, (5) inhalation phonation to stifle hyperactive ventricular fold activity during voice efforts, (6) gentle coughing or throat clearing gestures to stimulate voice production in patients with muscle tension (conversion) aphonia symptoms, (7) endoscopic visual feedback of intrinsic laryngeal activities during various vocal building maneuvers, (8) general vocal hygiene and patient education about voice misuse patterns, and (9) voice conservation strategies. Ramig and Verdolini concluded that there are many published reports that clearly demonstrate the value of both direct and indirect voice therapy programs for the treatment of patients with MTD.
Phonosurgical-pharmacologic techniques Carbon dioxide laser excision
Although voice therapy is considered the standard modality of treatment for MTD, there are patients who fail to respond even to intensive exercise regimens. In 1987, Feinstein, Hilger, Szachowicz, and Stimson [12] described use of the carbon dioxide laser for treatment of plicae ventricularis in those patients with MTD who are nonresponsive to behavioral intervention. The goal of such surgery was to prevent hyperadduction of the false vocal folds by partially excising these edematous structures. To date, the literature includes only a small number of patients who have undergone this surgical technique; postoperative outcomes have been variable, and long-term effects have not been detailed.
Botulinum toxin injection
In 1997, Kendall and Leonard [13] reported on seven patients with plicae ventricularis who were treated successfully with botulinum toxin (Botox; Allergen, Irvine, CA, USA) injections into the false vocal folds. To ensure accurate needle placement and patient comfort, these injections were performed in the operating room with the patient under general anesthesia. It was concluded by these researchers that Botox not only speeds recovery of normal voicing by relaxing the paraventricular musculature, but it also affords improved diagnostic visualization of the (once obscured) true vocal folds to rule out the possibility of underlying organic pathology. According to the authors, those patients with MTD who do not make significant gains in voice therapy may benefit from ventricular fold Botox injections. Large sample studies are lacking, as are reports on long-term effects. It should be noted that we have attempted similar injections in the office setting with poor results.
Topical lidocaine injection
In 2000, we [14] reported an alternative treatment technique using a topical anesthetic agent in patients with therapeutically recalcitrant MTD. Our current procedure consists of a 3 cc percutaneous, transcricothyroid membrane injection of 4% topical lidocaine. The injection results in an abrupt cough reflex that distributes the anesthetic over the tracheal, glottal, and supraglottal mucosa. Once the patient reports anesthesia of these tissues, typically within 5 minutes from the time of injection, a brief array of behavioral exercises, including pitch variations, easy vocal onset, and yawn-sigh phonation techniques, are implemented. In our original series of three patients with profound MTD symptoms, vocal quality returned to near normal within 15 minutes from the time of injection in each case. One patient underwent placebo injection of saline without symptom improvement but subsequently responded to the lidocaine method. To date, all patients have maintained normal phonation skills. We have since experienced excellent results with this treatment technique in several other patients with MTD.
The improved outcomes after lidocaine injection suggest that there may be a prominent sensory trigger underlying MTD. We propose that patients with this disorder may suffer from a hyperexcitable sensorimotor laryngeal feedback loop that alters prephonatory vocal fold position, length, and tension set points and causes sphincteric supraglottal and glottal muscular activity. The lidocaine bath potentially disrupts the sensory arm of this loop and desensitizes the densely populated mechanoreceptors of the tracheal and laryngeal mucosa. This so-called sensory trick enables the patient to produce voice deprived of the perverse, possibly selfgenerating, hyperactive laryngeal feedback. Breaking the hyperfunctional cycle with this technique has facilitated the reintroduction and value of behavioral exercises to improve phonation in our patients with MTD. The injection is an easy, quick, and well-tolerated inoffice procedure that can be performed in less than 5 minutes. Although we have used this treatment mostly as a secondary strategy for patients who failed voice therapy, it has also been successful as a primary approach in the management of other patients of ours who were disinterested in protracted therapy. In addition to its therapeutic benefits, the lidocaine technique has proved efficacious in relaxing the hyperactive, tonically contracted laryngeal musculature for improved visualization of true vocal fold anatomy and physiology. More recently, we have been exploring the use of nebulized lidocaine in lieu of the injection approach to minimize patient discomfort.
Conclusion
Summarily, MTD is a poorly understood disorder, and there exists limited clinical and data-based research focus on the subject. The pathophysiology of this unusual condition remains elusive, and unequivocal treatment approaches have not been well documented. As a consequence of these shortcomings, clinicians continue to operate in a vacuum when required to construct optimal therapy programs for patients who struggle with MTD. It should be obvious from the dearth of information presented in this review that additional investigations are sorely needed on this subject.
